On January 13th, 2017 CARE™ faculty specialists representing the fields of gastroenterology, hematology, oncology, respirology…
jwood@krftwrk.caJanuary 23, 2017
SABCS 2016. P4-22-13. Everolimus plus trastuzumab and paclitaxel as first-line therapy in women with HER2+…
jwood@krftwrk.caDecember 21, 2016
SABCS 2016. S1-03. First results from the multicenter phase III DATA study comparing 3 versus…
jwood@krftwrk.caDecember 21, 2016
ESMO 2016. LBA14_PR. FALCON: A phase III randomised trial of fulvestrant 500 mg vs. anastrozole…
jwood@krftwrk.caNovember 9, 2016
ESMO 2016. LBA8_PR. KEYNOTE-024: Pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) as first-line therapy for advanced…
jwood@krftwrk.caNovember 9, 2016
News in Lung Cancer ASCO 2015. Abstract 9001. Epidermal growth factor receptor (EGFR) genotyping of…
jwood@krftwrk.caJune 29, 2016
News in Prostate Cancer ASCO 2016. Abstract 5059. Effects of abiraterone (ABI) and enzalutamide (ENZA)…
jwood@krftwrk.caJune 29, 2016
Colorectal Cancer ASCO 2016. Abstract 3504. Impact of primary (1º) tumor location on overall survival…
jwood@krftwrk.caJune 29, 2016
Head and Neck Cancer ASCO 2016. Abstract 6008. BERIL-1: A phase II, placebo-controlled study of…
jwood@krftwrk.caJune 29, 2016
